Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2h-pryrazol-3-yl)-3-(4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl)-urea and a cyclodextrin
A Standard patent application filed on 08 August 2002 credited to Way, Susan L.
;
Cappola, Michael L.
Details
Application number :
2002319782
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2h-pryrazol-3-yl)-3-(4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl)-urea and a cyclodextrin